NGAL

Related by string. * * urine NGAL *

Related by context. All words. (Click for frequent words.) 71 cystatin C 71 cardiac troponin 69 cardiac troponin T 69 urine NGAL 69 neutrophil gelatinase associated lipocalin 68 cTnI 68 thyroglobulin 67 troponin T 66 cTnT 66 glomerular filtration rate 66 PlGF 66 HER2 expression 66 Her2/neu 66 HAAH 65 microsatellite instability 65 D dimer 65 lactate dehydrogenase LDH 65 D Dimer 65 myeloperoxidase 65 platelet reactivity 65 urine cytology 65 TPMT 65 serum creatinine 65 carcinoembryonic antigen 64 troponin 64 endoglin 64 Clusterin 64 renal cysts 64 PSADT 64 myocardial necrosis 64 lactate dehydrogenase 64 glomerular filtration 64 alkaline phosphatase ALP 64 gastric carcinoma 64 miRview mets 64 WT1 64 lymph node metastasis 64 immunohistochemical 64 peptide BNP 64 β amyloid 64 haematopoietic 63 creatinine levels 63 renal cell carcinomas 63 PCa 63 immunoblotting 63 galectin 3 63 tumorigenicity 63 FISH fluorescence 63 specific antigen PSA 63 clusterin 63 CIN2 + 63 protein albumin 63 albuminuria 63 thyrotropin 63 aminotransferase 63 immunostaining 63 gene amplification 63 AST ALT 63 HbF 63 Lp PLA 2 63 microalbuminuria 63 ImmuKnow 63 ELISPOT 63 VEGF expression 63 transgene expression 63 Troponin T 63 proteomic analysis 63 K ras 63 prostate carcinoma 63 leukocyte count 63 NT proBNP 63 B7 H3 63 transient elastography 63 Microalbuminuria 63 p tau 63 bronchoalveolar lavage 63 IgG antibodies 63 Western blotting 63 antigen PSA levels 63 ptau 63 alanine aminotransferase ALT 62 GRP# 62 cerebrospinal fluid CSF 62 RT qPCR 62 HGPIN 62 S#A# [002] 62 HER2 overexpression 62 Cystatin C 62 tumoral 62 chemosensitivity 62 RBP4 62 radioimmunoassay 62 RQ PCR 62 trophoblast cells 62 EUS FNA 62 biomarker 62 serum albumin 62 somatic mutations 62 troponins 62 p# activation 62 colorectal liver metastases 62 TIMP 62 #F FDG 62 GISTs 62 HSCT 62 Circulating tumor cells 62 tyrosine phosphorylation 62 chromosomal aberrations 62 eosinophilia 62 urothelial cancer 62 eosinophil count 62 prognostic markers 62 gene polymorphisms 62 ^ sup #m 62 F FDG PET 62 human leukocyte antigen 62 stratifying patients 62 procalcitonin 62 pT2 62 IUGR 62 prognostic indicator 62 pretargeting 62 ELISpot 62 P selectin 62 catheter angiography 62 MSMB 62 heterozygotes 62 vimentin 62 Immunohistochemical analysis 62 adrenalectomy 62 sFlt 1 62 PSA nadir 62 prognostic marker 62 intact parathyroid hormone 62 SCr 62 NPM1 62 noninvasive imaging 61 urothelial carcinoma 61 tissue oxygenation 61 serum lactate 61 reticulocytes 61 IgA deficiency 61 multivariable analysis 61 promoter methylation 61 thyroid stimulating hormone 61 HBsAg 61 transcranial Doppler 61 biomarkers 61 hepatorenal syndrome 61 serum thyroglobulin 61 skeletal metastases 61 K ras mutations 61 artery stenosis 61 sCJD 61 colorectal carcinomas 61 inducible nitric oxide synthase 61 serum creatinine levels 61 breast carcinomas 61 chromosomal mutations 61 epithelial tumors 61 immunohistochemical analysis 61 serum aminotransferase levels 61 ADPKD 61 airway hyperresponsiveness 61 G6PD 61 Endothelial dysfunction 61 pancreatic adenocarcinoma 61 liver metastasis 61 Elevated serum 61 glomerular 61 prospective multicenter study 61 follicle stimulating hormone FSH 61 postoperative mortality 61 cystatin 61 hepatocellular carcinomas 61 p# antigen 61 MammaPrint R 61 IL 1beta 61 annexin V 61 intraventricular 61 assay detects 61 p# MAPK 61 NMP# 61 ovarian malignancy 61 rs# [002] 61 TIMP 1 61 C Reactive Protein 61 cytogenic 61 Kupffer cells 61 hypoperfusion 61 transcranial Doppler ultrasound 61 urine dipstick 61 diagnostic biomarker 61 Immunohistochemistry 61 mRNA expression 61 serum calcium 61 serum urate levels 61 paricalcitol 61 interleukin IL -# 61 serum ferritin 61 micrometastasis 61 chromosomal rearrangement 61 CK MB 61 ABCB1 61 FDG uptake 61 IgG4 61 circulating EPCs 61 Immunohistochemical staining 61 prognostic biomarker 61 alanine aminotransferase 61 PD2i ® 61 LC-MS/MS 61 DNA methylation patterns 61 FLT3 61 vWF 61 NSCLC tumors 61 mtDNA mutations 61 histological subtype 61 immunohistochemical staining 61 NF kappaB activation 61 Acute renal failure 61 perfusion imaging 61 radioiodine therapy 61 diagnostic modality 61 PCA3 gene 61 ferritin 61 creatinine 60 pathologic examination 60 GSTP1 60 elevated creatinine 60 Alkaline Phosphatase 60 IgG antibody 60 macroalbuminuria 60 glycated hemoglobin levels 60 PCA3 60 T SPOT.TB 60 carotid stenosis 60 isoenzyme 60 fetuin 60 advanced neoplasia 60 Endometrial 60 hematopoietic cells 60 serum concentrations 60 hamartomas 60 coagulation abnormalities 60 apolipoproteins 60 carcinoid 60 IGFBP 60 prognostic significance 60 intracoronary 60 maternal serum 60 peripheral blood mononuclear 60 qRT PCR 60 malignant nodules 60 KRAS mutation 60 somatic mutation 60 Corus CAD 60 malignant lymphoma 60 LQTS 60 inflammatory biomarkers 60 obstructive coronary artery 60 LVNC 60 cardiac biomarkers 60 prostate cancer PCa 60 gastric adenocarcinoma 60 protein tyrosine phosphatase 60 normal karyotype 60 eTag assays 60 alkaline phosphatase 60 BCR ABL mutations 60 lymphocyte counts 60 intraobserver 60 KRAS oncogene 60 inotropic 60 exhaled nitric oxide 60 miRs 60 IFN γ 60 coronary stenosis 60 skin sterol 60 aneuploidies 60 IL 1ß 60 immunoglobulin G 60 monocyte chemoattractant protein 60 bone scintigraphy 60 TMPRSS2 ERG fusion 60 sarcosine 60 GIST tumors 60 virulence genes 60 advanced adenomas 60 Tr DNA 60 invasive coronary angiography 60 Allogeneic 60 specific antigen 60 renal tumors 60 immunoreactivity 60 VerifyNow 60 QTc prolongation 60 aspartate aminotransferase AST 60 herpesviruses 60 aminotransferases 60 myocardial perfusion 60 TNFalpha 60 pDCs 60 diagnose Alzheimer disease 60 thyroid nodules 60 IL#B 60 thyroid stimulating hormone TSH 60 APTIMA HPV 60 HepG2 cells 60 Lp PLA2 60 ACTH 60 serum cortisol 60 OGG1 60 intracranial hemorrhage ICH 60 intravesical therapy 60 oxysterols 60 nucleated cells 60 postoperative complication 60 NAGS deficiency 60 FDG PET 60 pCR 60 metastatic malignant 60 NPM1 mutation 60 Mesothelin 60 hepatectomy 60 MGUS 60 miRNA expression 60 immunomodulation 60 Prostate Specific Antigen PSA 60 histone acetylation 60 NQO1 60 SERCA2a 60 tryptase 60 molecular biomarkers 60 malignant ascites 60 stem cell engraftment 60 hemodilution 60 serologic 60 BRAF V#E mutation 60 STAT1 60 perioperative morbidity 60 univariate analysis 60 FDG-PET/CT 60 induced sputum 60 LV dysfunction 60 KCNE2 60 serum phosphate 60 posttransplant 60 autoantibodies 60 tumor necrosis 60 ABL1 60 metastatic neuroendocrine tumors 60 reaction RT PCR 60 prostate cancer CaP 60 thrombotic thrombocytopenic purpura TTP 60 Quantitation 60 lung metastasis 60 haematologic 60 ERCC1 60 angiographically 60 transferrin saturation 60 needle aspiration 60 colorectal adenoma 59 E. faecalis 59 endotoxemia 59 prion infection 59 IGFBP 3 59 hypermethylation 59 molecular diagnostic assay 59 #F FDG PET 59 tHcy 59 endothelial activation 59 esophageal carcinoma 59 transabdominal 59 transthoracic 59 osmolality 59 cerebral vasospasm 59 immunochemical 59 pretransplant 59 histopathologic 59 antibody titer 59 #m Tc 59 pretest probability 59 tumor biopsies 59 NAbs 59 Hurthle cell 59 d dimer 59 graft dysfunction 59 precursor lesions 59 sonographic diagnosis 59 TNFa 59 platelet function 59 nephrotoxicity 59 TGF alpha 59 albumin protein 59 SPECT CT imaging 59 metastatic lymph nodes 59 mesothelin 59 breast cancer metastasis 59 differentially expressed genes 59 Prostate Specific Antigen 59 hematopoietic cell 59 ADAMTS# 59 Hypotension 59 serum glucose 59 nutlin 3a 59 Cyclin E 59 fetal aneuploidy 59 Ki# 59 Doppler sonography 59 low expressors 59 mitochondrial toxicity 59 IL 1β 59 HRCT 59 allogeneic HSCT 59 microRNA expression 59 PIK3CA 59 PTLD 59 cellularity 59 edifoligide 59 chemoresistant 59 mammographic density 59 urine albumin 59 APOL1 59 albumin excretion rate 59 eGFR 59 Septin9 59 malignant transformation 59 Smad3 59 methylated DNA 59 surrogate markers 59 serum PSA 59 leiomyomas 59 BRAF mutation 59 proto oncogene 59 JMML 59 metaplasia 59 proBNP 59 KRAS mutations 59 antibody mediated 59 estrogen receptor ER 59 homodimer 59 hypericin 59 hsCRP 59 GRK2 59 tumor hypoxia 59 pericardial effusion 59 iNOS 59 amyloid deposition 59 pT3 59 platelet activation 59 estimated GFR 59 liver transplant recipients 59 chest radiographs 59 immunohistochemistry IHC 59 fibrin deposition 59 thrombocytosis 59 heparanase 59 lymphocyte count 59 hemoglobin Hb 59 PITX2 59 culture supernatants 59 TGF β 59 granulocyte 59 lymph node metastases 59 Pseudomonas aeruginosa infections 59 allogeneic hematopoietic stem cell 59 isotypes 59 STRIDE PD 59 IgA antibodies 59 genetic polymorphisms 59 inhibin 59 μmol L 59 busulfan 59 antigen PSA 59 SGPT 59 CLL cells 59 adrenomedullin 59 interobserver agreement 59 biochemical recurrence 59 metabolite concentrations 59 renal artery stenosis 59 VKORC1 59 nephrogenic 59 microalbumin 59 thyroid carcinoma 59 PEDF 59 myocardial viability 59 OGTT 59 SUVmax 59 clonogenic 59 Lipoprotein 59 sitosterol 59 neoplastic cells 59 virological response 59 histologic 59 cerebral oxygen saturation 59 small molecule activators 59 IFN beta 59 SpCO 59 Macrophage 59 anti JCV antibodies 59 creatine kinase 59 isoprostane 59 miRview squamous 59 atrioventricular block 59 APOE e4 59 TMPRSS2 ERG 59 follicle stimulating hormone 59 estimated glomerular filtration 59 acute aortic dissection 59 scintigraphic 59 urinary albumin 59 FDG PET imaging 59 splice variants 59 lupus anticoagulant 59 ERBB2 59 causal variants 59 FGFR3 59 Neutrophil 59 natriuretic peptide 59 von Willebrand factor 59 C1 INH 59 AtherOx 59 TOP2A 59 Oncotype 59 activating mutations 59 transthyretin 59 MSH2 59 decompensated heart failure 59 RIP1 59 peritoneal carcinomatosis 59 pulmonary metastases 59 analyte 59 tandem mass spectrometry 59 PTHrP 59 aggregated Abeta 59 androgen receptor AR 59 echocardiographic 59 adenomatous 59 immunoblot 59 mutant p# 59 ELISA assay 59 VEGF receptor 59 immunochemical fecal occult 58 histopathologic examination 58 NMIBC 58 Inhibin B 58 ubiquitinated 58 Papillary 58 BRAF mutations 58 biomarker assay 58 obstructive CAD 58 cardiac dysfunction 58 atypical hyperplasia 58 pelvic lymphadenectomy 58 Ferritin 58 uPA 58 papillary RCC 58 squamous intraepithelial lesions 58 TNF α 58 serum bilirubin 58 renal biopsy 58 iPTH 58 intracellular pH 58 neutrophil counts 58 stenoses 58 plasma pharmacokinetics 58 hematological parameters 58 follicular fluid 58 nondiabetic patients 58 creatine kinase MB 58 physiologically relevant 58 pleural fluid 58 transaminase levels 58 serum calcium levels 58 HMGA2 58 diabetes mellitus DM 58 SSc 58 allogeneic bone marrow 58 carcinoid tumors 58 RECAF 58 natriuretic peptides 58 GHRH 58 CMV infection 58 nestin 58 rtPA 58 interleukin IL -6 58 bronchogenic carcinoma 58 coronary artery stenosis 58 Lymph node 58 beta globin 58 tuberculin skin testing 58 bFGF 58 primary aldosteronism 58 biomarker identification 58 haematological 58 PCR assay 58 T2DM 58 ELISA assays 58 thrombotic complications 58 hs CRP 58 activated partial thromboplastin 58 vitro experiments 58 thymidine kinase 58 presymptomatic 58 protein biomarker 58 allogenic 58 assay ELISA 58 morphologic 58 arterial calcification 58 cytokine interleukin 58 MAPCs 58 protein excretion 58 neoplastic 58 thiopurine 58 Proteinuria 58 fluoroquinolone resistance 58 human chorionic gonadotropin hCG 58 adducts 58 plasma creatinine 58 BMP2 58 plasminogen activator inhibitor 58 artery embolization 58 parathyroidectomy 58 colorectal carcinoma 58 integrin expression 58 infarct size 58 glycosylated 58 N Myc 58 podocytes 58 cytokeratin 58 CD# expression [001] 58 aneuploidy 58 Hematopoietic 58 Prostate specific antigen 58 plasma renin activity 58 biochemical abnormalities 58 miRNA genes 58 MGd 58 cardiac perfusion 58 epididymal 58 hTERT 58 hydroxyvitamin D levels 58 systemic amyloidosis 58 NIHSS score 58 redox active 58 blood urea nitrogen 58 hydronephrosis 58 Troponin 58 SpMet 58 bladder carcinoma 58 renal fibrosis 58 interferon IFN 58 cell adhesion molecule 58 varicoceles 58 diagnosing coronary artery 58 CTAP# Capsules 58 pertussis toxin 58 IPAH 58 cell lysate 58 proteolytic cleavage 58 paraprotein 58 myo inositol 58 radiolabeled 58 microvessel density 58 intrahepatic 58 microglial activation 58 distant metastasis 58 preoperative PSA 58 pmol L 58 polyamine 58 polyomavirus nephropathy 58 missense mutation 58 ELISPOT assay 58 pheochromocytoma 58 CC genotype 58 postoperative morbidity 58 miRview ™ squamous 58 cytologic 58 BladderChek 58 penetrance 58 WNK1 58 histopathologic diagnosis 58 oncologic outcomes 58 glycosylated hemoglobin HbA1c 58 HER2 amplification 58 mycobacterial 58 mutant alleles 58 LHRH agonists 58 GPx 58 Endothelial 58 arterial oxygen saturation 58 preserved ejection fraction 58 constitutively expressed 58 metachronous 58 transesophageal echocardiography 58 cellular prion protein 58 reverse transcriptase polymerase chain 58 quantitative PCR 58 quantitate 58 basal cell nevus syndrome 58 HIF 1a 58 cyclic AMP cAMP 58 Upregulation 58 enzyme linked immunosorbent 58 triiodothyronine 58 intraoperative complications 58 polycystin 58 hyperphenylalaninemia HPA due 58 Creatinine 58 SMN protein 58 serum antibodies 58 circulating lymphocytes 58 interferon γ 58 tumor histology 58 serum markers 58 Leydig cell 58 IL #R 58 familial ALS 58 PC3 cells 58 MGMT gene 58 renal dysfunction 58 AlloMap 58 SNP rs# [001] 58 pg ml 58 haematopoietic stem cell 58 hypermethylated 58 radiosensitivity 58 mediated inhibition 58 chromosome aberrations 58 sortilin 58 antiphospholipid antibodies 58 left ventricular dysfunction 58 node metastases 58 adiponectin 58 serous ovarian cancer 58 caveolin 1 58 Xanafide 58 ductal cancer 58 papillary thyroid carcinoma 58 vessel occlusion 58 sequence homology 58 58 spectrophotometric 58 miRview TM mets 58 p#NTR 58 Cathepsin B 58 monoclonal gammopathy 58 LRP6 58 transcriptomic 58 EBUS FNA 58 activin 58 ischemic lesions 58 kidney allograft 58 liposomal amphotericin B 58 progesterone receptor PR 58 variceal hemorrhage 58 GRNCM1 58 Atypical Hemolytic Uremic Syndrome 58 serum IgE 58 serum IgG 58 paragangliomas 58 imatinib therapy 58 tracer uptake 58 c reactive protein 58 biochemical marker 58 soluble CD# ligand 58 mononuclear 58 replicase 58 calculated creatinine clearance 58 mononuclear cells 58 lipoprotein associated phospholipase 58 lobular carcinoma 58 proteoglycan 58 seropositivity 58 CD# expression [002] 58 plasma cortisol 58 Adenomas 58 microdeletions 58 tamponade 58 varices 58 epithelial ovarian cancer 58 pulmonary angiography 58 heterodimers 58 p#INK#a 58 Placental 58 IGRAs 58 vasopressor 58 mesangial 58 matrix metalloproteinase 58 Brugada syndrome 58 LRP5 58 monogenic 58 causative gene 57 midkine 57 osteopontin 57 gene rearrangements 57 factor PlGF 57 hyperacute 57 osteoblastic 57 serum potassium 57 Histologic 57 fulminant hepatic failure 57 SpHb 57 tumor recurrence 57 methylation 57 EphB4 57 hyperkalemia 57 IDH1 mutation 57 ligand induced 57 hyperglycaemia 57 Multivariate analysis 57 Immunohistochemical 57 G6PD deficiency 57 autoregulation 57 bcl 2 57 ERK1 2 57 genomic alterations 57 thymectomy 57 cathepsin B 57 methylation markers 57 apoptotic cells 57 SMN1 57 Myeloperoxidase 57 missense mutations 57 granzyme B 57 graft occlusion 57 hyperinsulinemic euglycemic clamp 57 guaiac 57 clinically detectable 57 prognostic factor 57 serine protease 57 latent tuberculosis infection 57 serum estradiol 57 spiral computed tomography 57 allogeneic stem cell 57 histologic subtype 57 leukocytosis 57 overt nephropathy 57 extramedullary 57 vivo potency 57 HBeAg 57 Cervista HPV HR 57 serum biomarker 57 antiangiogenic therapy 57 tenascin C 57 acinar cells 57 radical nephrectomy 57 cisplatin resistant 57 HCV infections 57 PGE2 57 ductal carcinomas 57 grade cervical intraepithelial 57 serum biomarkers 57 EGFR receptor 57 cervical carcinoma 57 Human Leukocyte Antigen 57 molecular abnormalities 57 CTEPH 57 differentially expressed proteins 57 pathologic 57 Akt activation 57 mucinous 57 MTT assay 57 isoprostanes 57 β1 57 hyperbilirubinemia 57 CMV reactivation 57 mismatched bone marrow 57 HE4 57 N telopeptide 57 PNH patients 57 p# INK4a 57 c MYC 57 S. maltophilia 57 serum triglyceride levels 57 MMP# 57 CYP#D# 57 neoadjuvant chemotherapy 57 adipogenic 57 florbetaben 57 IGF IR 57 paraganglioma 57 pancreatectomy 57 sDNA 57 immunofluorescence 57 prostanoid 57 invasive aspergillosis 57 plasma lipid 57 ventricular myocardium 57 demyelinating 57 nitrotyrosine 57 5alpha reductase 57 radiotherapy RT 57 detecting colorectal cancer 57 IFN gamma 57 CEACAM1 57 multiplex assay 57 Hyperlipidemia 57 N myc 57 pharmacologic intervention 57 multiplex PCR 57 PNA FISH TM 57 Prenatal diagnosis 57 lung biopsy 57 RRM1 57 preoperative diagnosis 57 chlamydial 57 quantitative polymerase chain 57 HER2 positive cancers 57 Hcy 57 EpCAM 57 hydroxylase 57 chromosomal instability 57 subclinical atherosclerosis 57 KRAS BRAF 57 tumor lysis syndrome 57 conventional coronary angiography 57 substrate specificity 57 chromosomal abnormalities 57 fluvastatin 57 situ hybridization 57 hemolytic 57 perioperatively 57 HIF 1alpha 57 subclinical hypothyroidism 57 differential gene expression 57 Leydig cells 57 CFTR gene 57 aminotransferase ALT 57 Western blot 57 nodal metastasis 57 renal artery stenting 57 JAK2 mutation 57 immunohistochemistry 57 laparoscopic radical nephrectomy 57 phosphoprotein 57 glutamic acid decarboxylase 57 MAPK pathway 57 Phosphorylation 57 lung resection 57 metastatic lesion 57 CT angiography CTA 57 advanced adenoma 57 bleomycin 57 thrombocytopenic 57 transgenic rats 57 hyperplasia 57 serum prostate 57 de novo mutations 57 ischemia reperfusion injury 57 prostate specific 57 lung adenocarcinomas 57 sonographic findings 57 biochemical relapse 57 pituitary adenomas 57 liver metastases 57 ectopic expression 57 multivariate analyzes 57 retinal ischemia 57 selective inhibition 57 unresectable tumors 57 overexpression 57 metabolomic profiles 57 HEK# cells 57 HOXB# 57 Notch1 57 putative biomarkers 57 hematopoietic 57 lobular carcinomas 57 transthoracic echocardiography 57 allogeneic transplants 57 familial aggregation 57 plasma kallikrein 57 murine models 57 osteoblast 57 fine needle aspiration 57 peroxisomal 57 pro angiogenic 57 GBM tumors 57 Cardiac Troponin 57 Coronary artery calcium 57 μg dL 57 intestinal polyps 57 AGTR1 57 surrogate endpoint 57 elevated uric acid 57 T#I [002] 57 rheumatoid factor 57 stent stenosis 57 chitinase 57 p# biomarker 57 cytomegalovirus infection 57 nucleotide substitutions 57 hydrops 57 MDRD equation 57 transcriptional profiling 57 mesotheliomas

Back to home page